arrow
F

Frederick L. Altice

Yale School of Medicine
H指数:74
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

War-related displacement, conflict intensity, and treatment delivery factors in opioid agonist maintenance treatment discontinuation following Russia's invasion of Ukraine: a national cohort study

战争相关流离失所、冲突强度及阿片类药物激动剂维持治疗中断的治疗交付因素:一项全国性队列研究

2026-08-260
OA
Using Nominal Group Technique With Human-Centered Design to Inform Preimplementation Planning for Combined Rapid-Start Initiation of Antiretroviral and Opioid Agonist Therapies in People Who Inject Drugs With HIV in Ukraine

采用名义小组技术与以人为中心的设计方法,为乌克兰注射毒品并感染HIV的人群联合快速启动抗逆转录病毒和阿片类药物激动剂治疗提供预实施规划指导

2026-05-010
PRE
Gatekeeping harm reduction in Canadian Federal Prisons: Perspectives on the threat risk assessment for the prison needle exchange program by prison administrative leadership

加拿大联邦监狱中的守门人式减害措施:监狱行政领导层对监狱针具交换计划威胁风险评估的观点

2026-03-050
OAAI
Global coverage of interventions for reduction of injecting drug use-related harm, HIV, viral hepatitis and tuberculosis in prisons and other carceral settings: A systematic review
2026-02-050
OAAI
Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids

阿片类药物依赖者对阿片类激动剂疗法的偏好相关因素

2025-12-040
OA
Pre-implementation findings on the barriers and potential solutions to initiate same-day antiretroviral therapy among people who inject drugs in Malaysia

实施前关于在马来西亚注射吸毒人群中开展当日抗逆转录病毒治疗所面临的障碍及潜在解决方案的发现

2025-08-260
PRE
A Dyad-Based Intervention to Improve Adherence to Antiretroviral Therapy among People with HIV who Inject Drugs in Kazakhstan: Results of a Randomized Controlled Trial

一种基于伴侣的干预措施以提高哈萨克斯坦注射吸毒人群中HIV患者的抗逆转录病毒疗法依从性:一项随机对照试验的结果

2025-08-070
PRE
Hepatitis C Virus (HCV) Clearance Cascade for Persons With Human Immunodeficiency Virus (HIV)/HCV Coinfection Using Health Department Surveillance Data Among 7 US Jurisdictions Highlights the Role of HIV Care Engagement

使用美国7个司法管辖区卫生部门监测数据,对人类免疫缺陷病毒(HIV)/丙型肝炎病毒(HCV)合并感染人群的丙型肝炎病毒清除级联分析,突显了参与HIV护理的重要性。

2025-08-010
PRE